Gastrointestinal Endoscopes- Global Pipeline Analysis -- GlobalData

July 1, 2011 - PRLog -- The global gastrointestinal (GI) endoscopes market valued $2 billion in 2010 is expected to reach $2.7
billion in 2017. Such an increase is largely a result of the increased adoption of capsule endoscope system, along with further advancements in technology and the availability of High Definition (HD)
systems, which are all expected to drive the market. Other factors driving the market are increased
prevalence of GI diseases such as Colorectal Cancer (CRC) and esophagitis, coupled with a growing
awareness of such diseases in the general population, which leads to increases in screening procedures.

Capsule endoscope systems market is the fastest growing amongst all other categories in the GI
Endoscopes market. The global capsule endoscope system market is expected to reach $323.6m in
2017, after growing at a CAGR of 8% during 2010–2017. The growth in the market is driven by improved
reimbursement coverage throughout developed economies and the increase in screening procedures of
the small bowel.

Reimbursement coverage for capsule endoscopy was initially only provided for the diagnosis of obscure
bleeding of the small bowel by third party payers. However, since December 2009, reimbursement was
extended for capsule endoscopy of the small bowel for suspected Crohn’s disease, tumors and other
pathologies. Several countries including the UK, France, Sweden and Denmark cover capsule endoscopy
for broader indications.

For Sample Pages, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/RequestSamplePages....

Another factor responsible for the fast growth of capsule endoscope systems is the growing number of
small bowel screening procedures. Small intestine pathologies have always been difficult to diagnose,
however capsule endoscopy has proved useful in diagnosing lesions, tumors and other pathologies that
are normally hidden inside mucosal layers. The efficiency of the capsule endoscope system in this area
has increased physician preference for small bowel investigations

The increasing adoption of new technologies such as HD cameras, narrow band imaging and confocal
endomicroscopy are currently driving the global GI endoscopes market.

In addition, there is also increased awareness and knowledge regarding disease conditions among
patients, which is resulting in an increasing number of screening procedures being conducted. For
example, since 2000 in the US, the month of March has been designated as the National Colorectal
Cancer Awareness Month. Similarly, the UK recently launched its ‘Be Clear on Cancer’ campaign in order
to increase awareness about bowel cancer. Such increasing awareness about symptoms and causes will
increase the number of screening procedures carried out by physicians thereby driving the growth in the
GI endoscopes market.

In 2010, Olympus Medical Systems Corporation with a market share of 56% continues to dominate the GI endoscopes market, followed by Fujinon, with 11% market share. Hoya Corporation, Given Imaging and Karl Storz GmbH also have significant presence in this market.

With a strong product portfolio and advanced technological products, Olympus is a key player in majority of categories in the GI endoscopes market. It is the market leader in the flexible endoscopes category, in which it holds a 67% market share. It is also the second largest company in the rigid endoscopes category, following Karl Storz GmbH. Despite the dominance of Given Imaging, Olympus is a key market player in the capsule endoscope systems category.

For further details, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/Report.aspx?ID=Gast...

Visit our report store: http://www.globaldata.com/reportstore

For more details contact:
pressreleases@globaldata.com

North America: +1 646 395 5477
Europe:       +44 207 753 4299
      +44 1204 543 533
Asia Pacific:    +91 40 6616 6782

# # #

GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage including oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries

End